{
  "trial_id": "NCT01029990",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "letter informing them they will be contacted by a midwife by phone, to be offered an appointment to take a smear.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "appointment to take a smear. They can at that stage decline such contact or if they wish return contact information (telephone number). A week later the women who have not declined will be called by a midwife and offered an appointment for taking a smear.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Abnormal smear will be followed up with referral to a gynecologist in concordance with normal screening routine.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Arm B: 800 women will be sent an offer of HPV-self sampling (Aprovix, Uppsala, Sweden). By regular mail the woman can order a test kit, and return this to the laboratory after sampling.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The samples will be tested with Hybrid Capture II for high risk HPV. A negative result will be communicated to the women. A positive result will be sent to the gynecological clinic responsible for the work up of abnormal cytological screening smears in the area were the woman lives.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "The afflicted woman will get information from the clinic and an appointment for colposcopy and cytology. Further investigation will be conducted as clinical routine.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Reminders will be sent to women who have ordered the kit and not returned any sample.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "In order to evaluate the effect of a primary reminder women who have not responded to the primary offer within 60 days will receive a reminder.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Arm C (controls) 4000 women will be controls. No specific action will be taken within the study outside routine in the screening program (yearly written reminder when smears are not found in the database).",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Methods: Data collection All data about cytology, colposcopy with biopsies and treatment for CIN are registered as a routine in the West Sweden Registry for Cervical Cancer Prevention and data will be extracted from that registry.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Data about HPV-testing will be transferred to this registry from the Aprovix laboratory in Uppsala.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Man-time needed and costs for material and analyses for the different interventions will be registered as base for health economic assessments.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Total hysterectomy",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. She has cervical cancer stage 1B and tested positive for HPV 16.",
  "_meta": {
    "topic_id": "31",
    "trial_id": "NCT01029990",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}